The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state
Open accessAbstract
Direct reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) provides a unique opportunity to derive patient-specific stem cells with potential applications in tissue replacement therapies and without the ethical concerns of human embryonic stem cells (hESCs). However, cellular senescence, which contributes to aging and restricted longevity, has been described as a barrier to the derivation of iPSCs. Here we demonstrate, using an optimized protocol, that cellular senescence is not a limit to reprogramming and that age-related cellular physiology is reversible. Thus, we show that our iPSCs generated from senescent and centenarian cells have reset telomere size, gene expression profiles, oxidative stress, and mitochondrial metabolism, and are indistinguishable from hESCs. Finally, we show that senescent and centenarian-derived pluripotent stem cells are able to redifferentiate into fully rejuvenated cells. These results provide new insights into iPSC technology and pave the way for regenerative medicine for aged patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, induction of pluripotency in iPSCs resets the age signatures of the donor cells to a fetal stage (7–9).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Telomere length decreases with age due to cell proliferation in the absence of telomerase enzymes and is restored upon complete iPSC reprogramming (Lapasset et al., 2011).”
From Multi-omic rejuvenation of human cells by maturation phase transient reprogramming (2022) · cites this paper as Lapasset et al., 2011
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The rejuvenation of aging hallmarks has been extensively described during cellular reprogramming to pluripotency in vitro (Lapasset et al., 2011;Liu et al., 2011;Mahmoudi and Brunet, 2012;Rando and Chang, 2012), but the dynamics of this process remain poorly understood.”
From In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. (2016) · cites this paper as Lapasset et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“Several groups, including ours, have observed an amelioration of age-associated cellular phenotypes during in vitro cellular reprogramming”
From In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. (2016) · cites this paper as Lapasset et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“iPSC reprogramming reverses many age-associated changes, including telomere attrition and oxidative stress (Lapasset et al., 2011).”
From Multi-omic rejuvenation of human cells by maturation phase transient reprogramming (2022) · cites this paper as Lapasset et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“Early reports using cells derived from old donors to generate iPS cells demonstrated beneficial effects on senescence phenotypes and telomere length [26][27][28] .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“but protocols relied upon rejuvenation through re-differentiation after iPS cell formation 20,26,28 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“Early experiments in human cells were somewhat encouraging as they provide evidence that some of the biomarkers of aging (that is telomere lengths) were responding to the epigenetic reprogramming”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [26]
In the citing paper
“Of note, senescent cells from elderly people could be reverted to a pluripotent state only by the additional over-expression of NANOG and LIN2 in addition to Oct3/4, Sox2, c-Myc, and KLF4.196”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [196]
In the citing paper
“A growing body of evidence, including the present study and a prior report of reprogramming of senescent human fibroblasts into induced pluripotent stem cells (iPSCs; ref. 48), suggests that near-senescent or senescent cells can be induced back into a proliferative state.”
From p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes (2013) · cites this paper as [48]
In the citing paper
“Reprogramming cells from elderly humans (as old as 101 years of age) into pluripotent cells erases many of the hallmarks of aging and restores a youthful gene expression profile that is maintained during differentiation (Lapasset et al., 2011; Mertens et al., 2015).”
From The Aging Epigenome (2016) · cites this paper as Lapasset et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Human induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“A common feature is the activation of the p53/p21 and p16/ pRb pathways, alteration of cell morphology and metabolism, increase in senescence-associated b-galactosidase (SA-b-Gal) activity, and formation of senescence-associated heterochromatic foci (SAHF) (Narita et al. 2003).”
BackgroundLinking the p53 tumour suppressor pathway to somatic cell reprogramming
Kawamura, T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., Wahl, G. M., & Belmonte, J. C. I. (2009) · Nature · doi:10.1038/nature08311 · Cited by 1,115
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
Marión, R. M., Strati, K., Li, H., Murga, M., Blanco, R., Ortega, S., Fernandez-Capetillo, O., Serrano, M., & Blasco, M. A. (2009) · Nature · doi:10.1038/nature08287 · Cited by 1,028 · cited 1×
“It has been reported by several groups that cellular senescence is a barrier to reprogramming due to upregulation of p53, p16, and p21, which are also induced by some of the iPSC reprogramming factors (Banito et al. 2009; Kawamura et al. 2009; Li et al. 2009; Marion et al. 2009a; Utikal et al. 2009).”
BackgroundThe Ink4/Arf locus is a barrier for iPS cell reprogramming
Li, H., Collado, M., Villasante, A., Strati, K., Ortega, S., Cañamero, M., Blasco, M. A., & Serrano, M. (2009) · Nature · doi:10.1038/nature08290 · Cited by 968
Direct cell reprogramming is a stochastic process amenable to acceleration
Hanna, J., Saha, K., Pando, B., van Zon, J., Lengner, C. J., Creyghton, M. P., van Oudenaarden, A., & Jaenisch, R. (2009) · Nature · doi:10.1038/nature08592 · Cited by 938
Immortalization eliminates a roadblock during cellular reprogramming into iPS cells
Utikal, J. S., Polo, J. M., Stadtfeld, M., Maherali, N., Kulalert, W., Walsh, R. M., Khalil, A., Rheinwald, J. G., & Hochedlinger, K. (2009) · Nature · doi:10.1038/nature08285 · Cited by 853
Cited by
Sorted by citations
Items 501–570 of 570
Therapeutic approaches for the treatment of aging-induced stem cell dysfunction
Bizzaro, D., Russo, F. P., & Burra, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820071-1.00018-9
Generating Isogenic Models of Li-Fraumeni Syndrome and Restoring p53 using CRISPR
Tran, J. (2020) · TSpace (University of Toronto)
Induced pluripotent stem cells as models for Amyotrophic Lateral Sclerosis
Ofir, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85764-2.00001-6
Injury and regeneration in renal aging
Bábíčková, J., Yang, H., & Fogo, A. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823318-4.00032-9
Mechanisms of adipose-derived stem cell aging and the impact on therapeutic potential
Shan, X., & Percec, I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819376-1.00017-2
VI. Sur la maintenance et l’évolution de la vie
Radman, M. (2017) · Hermann eBooks · doi:10.3917/herm.caros.2017.01.0063
Goldsmith, T. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_60
Goldsmith, T. C. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_60-1
New Insights in Spermatogonial Stem Cells
Conrad, S., Azizi, H., Amirian, M., Hatami, M., & Skutella, T. (2022) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-90111-0_6
Marsellach, X. (2021) · Preprints.org · doi:10.20944/preprints202012.0506.v3
Genodermatoses with Premature Aging/Syndromes
Chedraoui, A., Kibbi, A. G., & Kurban, M. (2016) · Springer eBooks · doi:10.1007/978-3-662-47398-6_132
Direct induction of neural cells from somatic cells
Akamatsu, W., & Okano, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813955-4.00013-1
Ramos, F. S. D. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2016.tde-06112020-162050
Elimination of damaged cells-dependent antiaging strategy
Naik, R. A., Dubey, V., Rajpoot, R., Dash, D., Gupta, N., & Koiri, R. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90235-9.00013-6
Overview of various antiaging strategies
Kumar, D., & Ahmad, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90235-9.00008-2
Reprogramación celular para implementar rejuvenecimiento, manipular el reloj epigenético
Chiavellini, P. (2023) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/151503
Tsitkov, S., Valentine, K., Kozareva, V., Donde, A., Frank, A. P., Lei, S., Eyk, J. E. V., Finkbeiner, S. M., Rothstein, J. D., Thompson, L. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.11.557005
Reprogramación celular y rejuvenecimiento: aplicación en el cerebro senil
Canatelli-Mallat, M. (2023) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/160047
Fülöp, T., Cohen, A. A., Larbi, A., & Witkowski, J. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-55022-5_10
Postnatal epigenome-mediated aging control and global trends
Hayano, M. (2024) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.61.1
Partial Cell Reprogramming as a Method of Revitalizing Living Systems
Shorokhova, M. (2023) · Tsitologiya · doi:10.31857/s0041377123060093
Roles of Ipsc in Advancing Treatments for Neurological DisordersPreprint
Zhang, X. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4818803
Engineering principles for rationally design therapeutic strategies against hepatocellular carcinoma
Hernández-Magaña, A., Bensussen, A., Martínez‐García, J. C., & Alvarez-Buylla, E. R. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1404319
Resolving chromatin interaction and transcriptional networks in mammalian nuclei
Zhu, Y. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10618
Neural cells derived from pluripotent stem cells and directly induced from somatic cells
Okano, H., & Akamatsu, W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00023-6
Umrath, F., Wendt, V., Gasparoni, G., Narknava, Y., Walter, J., Lethaus, B., Weber, M., Carriel, V., Avci‐Adali, M., & Alexander, D. (2025) · Cells · doi:10.3390/cells14090627
“On the other hand, it has been shown that iMSCs derived from adult MSCs show signs of rejuvenation compared to the originating cells [18–20].”
Wani, S. N., Zahoor, I., Tantray, J., Venkateshwarlu, G., Tiwari, P., Eqbal, S., Faiyazuddin, M., & Syed, A. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-91790-5_6
Inhibition of mesenchymal drift as a strategy for rejuvenation
Camillo, L. P. D. L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1715559
“This intermediate state was associated with early mesenchymal-to-epithelial transition (MET), reduced β -galactosidase activity by 40% – 60%, and rejuvenated transcriptional pro fi les within 7 days (Lapasset et al., 2011; Takahashi and Yamanaka, 2006).”
Health and aging: Navigating through the golden years
Multani, J., Multani, S., Leidy, N., Johar, T., Sobti, R. C., & Singh, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-38325-0.00008-3
Steg, L. C., Shireby, G. L., Imm, J. L., Davies, J. P., Franklin, A., Flynn, R., Namboori, S. C., Bhinge, A., Jeffries, A. R., Burrage, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14853126
Steg, L. C., Shireby, G. L., Imm, J. L., Davies, J. P., Franklin, A., Flynn, R., Namboori, S. C., Bhinge, A., Jeffries, A. R., Burrage, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14853114
Steg, L. C., Shireby, G. L., Imm, J. L., Davies, J. P., Franklin, A., Flynn, R., Namboori, S. C., Bhinge, A., Jeffries, A. R., Burrage, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14853123
Steg, L. C., Shireby, G. L., Imm, J. L., Davies, J. P., Franklin, A., Flynn, R., Namboori, S. C., Bhinge, A., Jeffries, A. R., Burrage, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14853120
Steg, L. C., Shireby, G. L., Imm, J. L., Davies, J. P., Franklin, A., Flynn, R., Namboori, S. C., Bhinge, A., Jeffries, A. R., Burrage, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14853117
Philipot, D. (2012) · theses.fr (ABES) · doi:10.70675/9b4773fdz718bz4ff2za6ebz25081c8e24f5
Lemacon, D. S. (2014) · theses.fr (ABES) · doi:10.70675/7fd8b535z1f0cz4646zb10eze941144f55e2
Dynamique de la réplication dans les cellules souches pluripotentes
Bialic, M. (2016) · theses.fr (ABES) · doi:10.70675/85996e74zbfe4z46aez9c39ze6cf738079b8
Hammoud, A. A. (2015) · theses.fr (ABES) · doi:10.70675/69fcb3faz5934z4940zbfe4z6caed8b6b168
Aït-Hamou, N. (2016) · theses.fr (ABES) · doi:10.70675/005b27ebz3792z4cc1zacb7zae990c676666
Self-citationLaaref, A. M. (2017) · theses.fr (ABES) · doi:10.70675/c2cfd784z5dd2z47cez9ddcz4ee6e8af424e
Auboyer, L. (2018) · theses.fr (ABES) · doi:10.70675/07243ef7zb974z4ad8z97d9zd046801798b1
“, 2011) car ils faciliteraient la division cellulaire et peuvent favoriser le processus de reprogrammation, en particulier dans les cellules sénescentes (Lapasset et al., 2011).”
BackgroundCaractérisation fonctionnelle de la tolérance aux endommagements de l’ADN des embryons précoces
Furno, E. L. (2019) · theses.fr (ABES) · doi:10.70675/cf32bcd5z3031z4693z8b1bz62fe76673ccc
Dissecting the non-cell autonomous impact of cellular senescence on cellular reprogramming
von Joest, M. (2019) · theses.fr (ABES) · doi:10.70675/01382339z05d9z4aacz911dz62afcc7c9191
Amélioration de la régénération cellulaire et tissulaire au cours du vieillissement
Alle, Q. (2020) · theses.fr (ABES) · doi:10.70675/932e617bzcb45z4332z8badzfda37d5299a8
Mazeyrie, L. (2024) · theses.fr (ABES) · doi:10.70675/04dabd62z8f26z4393zac25z0070faaa4fb9
Magnano, M., Wehbi, A., Shidi, F. A. R., Soubeyrand, M., Desprat, R., Bensadoun, P., Isidor, B., Gâtinois, V., Pellestor, F., Cruz, P. L., et al. (2026) · Stem Cell Research · doi:10.1016/j.scr.2026.103991
Self-citationCellular reprogramming for reverse aging
Mishra, P. K., Ghosh, S., Singh, D. K. K., & Sinha, J. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33159-6.00001-1
Rejuvenating stem cells to reverse aging
Ranwa, S., Yadav, S., Nurboo, S., & Nazir, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33159-6.00019-9
Developing a Clinically Practical Biomaterial Platform for Endogenous Liver Regeneration
Beamish, C., Abounorinejad, F., Kim, D. K., Tong, A. P., Barri, H., Marx, C., Lane, D., McGregor, H., Laidlaw, G., Jeffries, J., et al. (2026) · Gels · doi:10.3390/gels12050426
“Among the types explored, iPSCs and MSCs are most prominent. iPSCs, reprogrammed from somatic cells like dental pulp, are patient-specific, reducing the risk of immune rejection [175].”
A cross-talk between p16High senescence and cellular reprogramming
Emelyanov, A., & Bulavin, D. V. (2026) · Clinical Science · doi:10.1042/cs20260240
“This may also be the case in fibroblasts obtained from older individuals, where a fraction of cells does not express p16 at high levels and is therefore amenable to reprogramming [75].”
Jumping the clock: Engineering ageing in biomedicine
Samal, P., & Truckenmüller, R. K. (2026) · Trends in biotechnology · doi:10.1016/j.tibtech.2026.05.019
Functional rejuvenation of endothelial cell aging by transient reprogramming
Kalies, K., Knoepp, K., Hehl, L., Guerlach, S., Sandiano, L., Simm, A., Dutzmann, J., & Sedding, D. (2026) · Basic Research in Cardiology · doi:10.1007/s00395-026-01192-7
“Similar changes have been reported in the context of iPSC generation, where telomere maintenance or elongation can occur [29, 37].”
Kelm, R. C. (2026) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.71076
Godlewski, A., Wróblewski, M., Kuk, J., Moritz, M., Dobrak, F., Kołodziejska, R., & Woźniak, A. (2026) · Genes · doi:10.3390/genes17080964
Ji, Z., Yu, Y., Cao, Q., Luo, D., Xu, H., Xu, H., Zhou, Y., Ma, M., Wang, G., Yin, Z., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.181742
The significance of iPSC research in geriatric medicine
加瀬, 義. (2026) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.63.169
Bratt‐Leal, A. M., Gorba, T., Williams, R. M., Mossman, J. A., Hills, R., Tran, H., Barken, D. M., Beauvais, G., Fremgen, D. M., Zhang, A., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.08.014
From Primary Cells to Organoids: Expanding the Biological Relevance of In Vitro Cellular Models
Deng, F., Wang, Y., Castellano, L. A., & Zhao, C. (2026) · Cells · doi:10.3390/cells15191741
“Notably, the six-factor OSKMNL cocktail has been shown to enhance reprogramming efficiency and enable the generation of iPSCs from senescent and centenarian donor cells, which represent challenging starting populations for iPSC generation [119,120].”
Esmaeili, H., Das, S., Rytel, K., Sidransky, E., & Chen, Y. (2026) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2026.110265
Baek, K., Ahn, Y. J., Kim, J.-S., & Lee, A. Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198609
“Moreover, reprogramming through a pluripotent state can reset age-associated cellular features, potentially weakening the fidelity of iPSC-derived models intended to represent late-life sarcopenia [41].”
An age-preserving neuronal iSpheroid platform for modeling human aging and Alzheimer’s diseasePreprint
Alsolami, S., Wang, M., Sabedot, T. S., Singh, U., Kirk, B., Mitchell, L. E., Hernandez, M., Skvir, N. J., Bowman, C., Oiwa, K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.30.755853
Berg, L. J., Franzen, J., Buneß, A., Konang, R., Sheng, C., Peitz, M., Till, A., Wagner, W., & Brüstle, O. (2026) · Aging Cell · doi:10.1111/acel.70751
“…reflected by the length of telomeres, mitochondrial health, nuclear organization and the extent of transcriptional senescence signatures (Kim et al., 2018; Lapasset et al., 2011; Mertens et al., 2015; Miller et al., 2013; Prigione et al., 2011; Tang, Liu, Zang, & Zhang, 2017; Yang et al., 2015) .”
Transcriptomic reprogramming screen identifies SRSF1 as a regulator of aging
Pleşa, A. M., Jung, S., Wang, H. H., Omar, F., Shadpour, M., Buentello, D. C., Pérez-Matos, M. C., Horwitz, N., Cai, G., Ngian, Z., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01234-8 · Cited by 8
Testing the Hypothesis of Centriolar Entropy as a Source of Transcriptomic Aging-Clock Signal
Tkemaladze, J. (2026) · Longevity Horizon · doi:10.65649/hreta9r8 · Cited by 2
“Reprogramming-induced rejuvenation is an established phenomenon (Lapasset et al., 2011 — telomeres and oxidative stress reset through the pluripotent state); Experiment D asks the centriole-specific question — whether the centriolar counter resets with the transcriptome or persists (Tqemaladze,…”
Metadata
- Authors
- Lapasset, L., Milhavet, O., Prieur, A., Besnard, E., Babled, A., Aït-Hamou, N., Leschik, J., Pellestor, F., Ramirez, J.-M., De Vos, J., Lehmann, S., & Lemaitre, J.-M.
- Affiliations
- Institut de Génomique Fonctionnelle (FR)
- Hôpital Arnaud de Villeneuve (FR)
- Hôpital Saint Eloi (FR)
- Institut de Génétique Humaine (FR)
- ORCID
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2011-11-01
- Volume
- 25
- Issue
- 21
- Pages
- 2248-2253
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC3219229
- OpenAlex
- W2114840727
- Cited by
- 570
- References
- 31
- Citations by year
- 2026: 30 · 2025: 41 · 2024: 46 · 2023: 49 · 2022: 53 · 2021: 49 · 2020: 38 · 2019: 40 · 2018: 49 · 2017: 33 · 2016: 33 · 2015: 30 · 2014: 29 · 2013: 25 · 2012: 23
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-07-BLAN-0076)
- Institut National de la Santé et de la Recherche Médicale
- Institut National Du Cancer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- cellular senescence, induced pluripotent stem cells, direct reprogramming, aging, telomere length, oxidative stress, mitochondrial metabolism, gene expression profiles, redifferentiation, rejuvenation, regenerative medicine
- MeSH terms
- Aged, Aged, 80 and over, Animals, Cell Differentiation, Cell Line, Cells, Cultured, Humans, Mitochondria, Rejuvenation, Transcription Factors, Mice, SCID, Telomere, Mice, Inbred NOD, Cellular Senescence, Mice, Induced Pluripotent Stem Cells, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
